In April 2019, the company acquired the iovera system, a handheld cryoanalgesia
device used to deliver precise, controlled doses of cold temperature only to targeted nerves.
The iovera[degrees] system provides a handheld alternative to physicians for the delivery of cryoanalgesia
(the reversible destruction of the signal carrying parts of a nerve).
MyoScience currently markets the iovera system, a novel, FDA-approved non-opioid treatment that alleviates pain through a mechanism known as cryoanalgesia
, which applies intensely focused cold therapy to a specific nerve to interrupt its ability to transmit a pain signal.
Nally, "The role of cryotherapy (cryoanalgesia
) in the management of paroxysmal trigeminal neuralgia: A six year experience," British Journal of Oral and Maxillofacial Surgery, vol.